When should the 13-valent vaccine be started, in terms of months?

May 10, 2023 Source: Cainiu Health

Dr. Lv Aiming

Introduction

The 13-valent vaccine clinically refers to the 13-valent pneumococcal polysaccharide conjugate vaccine, which can prevent infections caused by 13 types of Streptococcus pneumoniae, including meningitis, bacteremic pneumonia, sepsis, and other diseases. It is generally administered as one dose at 2, 4, and 6 months after birth, followed by booster doses at 12 and 15 months of age. After vaccination, long-lasting protective antibodies are produced in the body.

　　In clinical practice, the 13-valent vaccine refers to the 13-valent pneumococcal polysaccharide conjugate vaccine. It is generally administered as one dose at 2, 4, and 6 months after birth, with booster doses given at 12 and 15 months for optimal effectiveness. The details are as follows:

　　The 13-valent pneumococcal polysaccharide conjugate vaccine can prevent infections caused by 13 types of Streptococcus pneumoniae, including meningitis, bacteremic pneumonia, sepsis, and other diseases. It is used to prevent pneumococcal infections in infants and young children aged 6 weeks to 15 months. Typically, primary immunization is required at 2, 4, and 6 months of age, followed by booster doses at 12 and 15 months. After vaccination, long-lasting protective antibodies are produced in the body.

　　Some children may have allergic reactions or other adverse responses to the 13-valent pneumococcal polysaccharide conjugate vaccine; therefore, professional medical advice should be followed before vaccination.

Related Articles

View All

Is it necessary to receive the 13-valent pneumococcal polysaccharide conjugate vaccine after one year of age?

It is usually necessary to receive the 13-valent pneumococcal conjugate vaccine after 1 year of age, but specific recommendations should follow medical advice. The 13-valent pneumococcal conjugate vaccine can prevent infections caused by 13 serotypes of Streptococcus pneumoniae and provides protection against more than 90% of invasive pneumococcal pneumonia, offering effective prevention. It generally protects against invasive diseases caused by these 13 pneumococcal serotypes.

View Full Answer

Is it too late for an 8-month-old baby to receive the 13-valent pneumococcal polysaccharide conjugate vaccine?

It is not too late to administer the 13-valent pneumococcal polysaccharide conjugate vaccine to an 8-month-old baby. This vaccine is indicated for infants and young children aged 6 weeks to 15 months. For infants aged 7–11 months, the primary immunization consists of 2 doses administered at least 2 months apart, followed by a booster dose after 12 months of age, with at least a 2-month interval from the second dose.

View Full Answer

How long will a child cry after receiving the 13-valent pneumococcal vaccine?

After receiving the 13-valent pneumococcal vaccine, a child may cry intermittently for about three days, with crying possibly more pronounced at night than during the day. If the crying persists without improvement or if adverse reactions significantly worsen, prompt medical attention is recommended. Additionally, after vaccination, parents should pay attention to the child's diet—avoiding highly stimulating foods and instead providing warm, easily digestible meals.

View Full Answer

Is it necessary to receive the 13-valent vaccine?

If financially feasible, vaccination is strongly recommended. The 13-valent vaccine is the 13-valent pneumococcal conjugate vaccine, which protects against infections caused by multiple serotypes of *Streptococcus pneumoniae*. Children under 5 years of age and adults over 60 have significantly weakened immune systems, rendering them highly susceptible to various pathogenic microorganisms; consequently, their risk of developing pneumonia due to *Streptococcus pneumoniae* infection is substantially increased.

View Full Answer

How long after receiving the 13-valent vaccine will fever occur?

Fever generally refers to elevated body temperature. The "13-valent vaccine" refers to the 13-valent pneumococcal polysaccharide conjugate vaccine. It is incorrect to assume a specific timeframe for developing fever, as not everyone will experience fever after vaccination. Individual physical conditions vary, leading to different reactions to vaccines; therefore, not all vaccinated individuals will develop fever. If fever does occur, it typically does not last more than 48 hours after vaccination.

View Full Answer

Which site should the 13-valent vaccine be administered?

Clinically, the 13-valent vaccine refers to the 13-valent pneumococcal polysaccharide conjugate vaccine. This vaccine is usually administered into the lateral deltoid muscle of the upper arm or the anterolateral thigh muscle. Injecting the vaccine at these sites helps ensure its optimal effectiveness. Before receiving the 13-valent pneumococcal polysaccharide conjugate vaccine, it is important to inform the doctor about your actual health condition truthfully.

View Full Answer

Can I directly receive the final dose of the 13-valent vaccine?

The term "13-valent" usually refers to the 13-valent pneumococcal polysaccharide conjugate vaccine, which generally cannot be administered as a single final dose without following the complete schedule. The analysis is as follows: The 13-valent pneumococcal polysaccharide conjugate vaccine is typically a preventive vaccine used to protect against invasive diseases caused by 13 types of Streptococcus pneumoniae. It is commonly used to prevent bacteremia, pneumonia, meningitis, and other conditions. The vaccination series is usually administered between 6 weeks and 5 months of age.

View Full Answer

Is it too late to get the 13-valent vaccine at nine months?

It is generally considered quite late to receive the 13-valent vaccine at nine months of age. The 13-valent vaccine, also known as the 13-valent pneumococcal vaccine, is primarily intended for infants aged 6 to 15 months. Typically, four doses are required: it is recommended to administer one dose each at 2 months, 4 months, and 6 months of age as primary immunization, followed by a booster dose between 12 and 15 months of age. This schedule helps infants develop sustained immunity.

View Full Answer

Your trusted source for health information and wellness guidance.

Quick Links

Resources

Connect

© 2024 HealthPortal. All rights reserved.